Higashi Kenjirou
Graduate School of Pharmaceutical Sciences, Chiba University.
Yakugaku Zasshi. 2021;141(9):1063-1069. doi: 10.1248/yakushi.21-00124.
70-90% of recently developed new drug candidates are poorly soluble in water, which creates a series of thorny challenges in developing its oral dosage forms, resulting in low bioavailability. In pre-formulation study, various specialized formulations have been developed to improve drug solubility. Intermolecular interactions between drug and excipients in the formulations can modify the drug state and achieve the improvement of drug solubility. Therefore, the understanding of intermolecular interaction is essential to design formulations with higher quality and to assure the quality as a pharmaceutical product. Solid-state NMR has attracted much attention as a promising method to evaluate the molecular state of a drug and the interaction between a drug and excipient in its formulation. I have applied solid-state NMR and its characteristic technique, namely magic-angle spinning (MAS), for various specialized formulations including amorphous solid dispersion, supersaturated solution, drug-loaded organic nanotube, and drug nanosuspension. The intermolecular interactions of drug and excipient in amorphous solid dispersion have been identified by C and N solid-state NMR. High-resolution MAS determined the interaction modes of drug and excipient in a supersaturated solution. The two-step dissolution profile of drug from organic nanotube was understood, based on the molecular states revealed by the combination of various solid-state NMR techniques. A suspended-state NMR clarified the nanostructure of drug nanoparticles dispersed in water. It is expected that more qualified pharmaceutical formulations with improved drug solubility can be designed based on the remarkable development of recent solid-state NMR technology.
最近研发的新药候选物中有70 - 90%在水中的溶解度很差,这在开发其口服剂型时带来了一系列棘手的挑战,导致生物利用度较低。在处方前研究中,已经开发了各种特殊剂型来提高药物溶解度。剂型中药物与辅料之间的分子间相互作用可以改变药物状态,从而提高药物溶解度。因此,了解分子间相互作用对于设计更高质量的剂型以及确保药品质量至关重要。作为一种评估药物分子状态及其在剂型中与辅料相互作用的有前景的方法,固态核磁共振受到了广泛关注。我已将固态核磁共振及其特色技术,即魔角旋转(MAS),应用于各种特殊剂型,包括无定形固体分散体、过饱和溶液、载药有机纳米管和药物纳米混悬液。通过碳和氮固态核磁共振确定了无定形固体分散体中药物与辅料的分子间相互作用。高分辨率MAS确定了过饱和溶液中药物与辅料的相互作用模式。基于各种固态核磁共振技术相结合所揭示的分子状态,理解了药物从有机纳米管中的两步溶出曲线。悬浮态核磁共振阐明了分散在水中的药物纳米颗粒的纳米结构。基于近期固态核磁共振技术的显著发展,有望设计出更多具有改善药物溶解度的优质药物剂型。